Hydropothecary releases versatile Decarb Micro THC and Decarb Micro CBD medical marijuana powders at $3 per gram
November 3rd, 2017
News, Top News
GATINEAU, QC–(Marketwired – November 03, 2017) – The Hydropothecary Corporation (“Hydropothecary” or the “Company”) (TSX VENTURE: THCX) is pleased to announce the release of two new products, Decarb Micro THC and Decarb Micro CBD. Part of the Company’s unique innovative line of Decarb products, Decarb Micro THC and Decarb Micro CBD are ready-to-consume, activated medical marijuana powders.
Decarb Micro allows clients to adjust their consumption of medical cannabis through the intake of minimal amounts of THC or CBD. Periodic use of Decarb Micro allows clients to help maintain their cannabinoid levels throughout the day.
In response to the needs of medical cannabis patients, the Company’s Decarb Micro products will be priced at $3 per gram, making Decarb Micro THC and Decarb Micro CBD amongst the lowest priced premium cannabis products on the market.
“With our Decarb Micro products, we have created a much-needed offering at an affordable price point, designed to provide patients the ability to maximize the benefits of medical cannabis through greater control of their cannabinoid intake levels,” said Hydropothecary CEO and co-founder, Sebastien St-Louis.
Decarb Micro THC and Decarb Micro CBD can be used along with the Hydropothecary’s CannaCap capsules and capsule maker. Hydropothecary’s Decarb products are created by a proprietary drying method that employs exacting scientific standards to decarboxylate (decarb) the cannabis and activate the cannabinoids (THC and CBD). Micro Decarb products provide a flexible and discreet alternative to smoking, vaping and oils, since the powder can be taken in capsules or incorporated into food or drinks.
“This new release is the latest example of Hydropothecary’s on-going commitment to product innovation and our focus on customer needs. Decarb Micro THC and Decarb Micro CBD ensure our clients have flexibility together with affordable, discreet and easy-to-understand products,” noted Mr. St-Louis.
About The Hydropothecary Corporation
The Hydropothecary Corporation is an authorized licensed producer and distributor of medical cannabis licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations (Canada). Hydropothecary provides sun grown and rigorously tested medical cannabis of uncompromising quality. Hydropothecary’s branding, cannabis product offering, patient service standards and product pricing are consistent with THCX’s positioning as a premium brand for a legal source for medical cannabis within this new marketplace. In addition to medical cannabis production and sales, Hydropothecary explores various research and development opportunities for cannabinoid extracts, drugs and combinatory chemistry. In addition, the company is investigating the development and patenting of novel technologies related to medical cannabis, as well as the import and export of medical cannabis.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Hydropothecary Product Facts
Number of Hydropothecary medical marijuana products available: 20
Number of kosher-certified medical marijuana products currently available: 7
Price range on per gram products: $3 to $15
Release date of Elixir No.1, Canada’s first sublingual cannabis oil mist: July 2017
Number of Decarb fine milled medical marijuana products: 6
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.